Cognitive Impairment in Patients with Cardiac Disease: Implications for Clinical Practice

Astrid C. Van Nieuwkerk; Ronak Delewi; Frank J. Wolters; Majon Muller; Mat Daemen; Geert Jan Biessels

doi:10.1161/STROKEAHA.123.040499

Cognitive Impairment in Patients with Cardiac Disease: Implications for Clinical Practice

Astrid C. Van Nieuwkerk, Ronak Delewi, Frank J. Wolters, Majon Muller, Mat Daemen, Geert Jan Biessels^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › Academic › peer-review

50 Citations (Scopus)

Abstract

Cognitive impairment is common in patients with cardiovascular disease. One in 3 patients presenting at cardiology clinics have some degree of cognitive impairment, depending on the cardiac condition, comorbidities, and age. In up to half of these cases cognitive impairment may go unrecognized; however, it may affect self-management and treatment adherence. The high prevalence of cognitive impairment in patients with cardiac disease is likely due to shared risk factors, as well as direct consequences of cardiac dysfunction on the brain. Moreover, cardiac interventions may have beneficial as well as adverse effects on cognitive functioning. In this review, we describe prevalence and risk factors for cognitive impairment in patients with several common cardiac conditions: heart failure, coronary artery disease, and aortic valve stenosis. We discuss the potential effects of guideline-based treatments on cognition and identify open questions and unmet needs. Given the high prevalence of unrecognized cognitive impairment in cardiac patients, we recommend a stepwise approach to improve detection and management of cognitive impairment.

Original language	English
Pages (from-to)	2181-2191
Number of pages	11
Journal	Stroke
Volume	54
Issue number	8
DOIs	https://doi.org/10.1161/STROKEAHA.123.040499
Publication status	Published - Aug 2023

Bibliographical note

Funding Information:
Dr Wolters was consultant for the PGGM pension fund (fees paid to institution) and received research grants from the Brain & Behavior Research Foundation, The Netherlands Organisation for Health Research and Development (ZonMw) and The Alzheimer’s Association, outside of the submitted work. Dr Biessels also receives research funding from The Netherlands Organisation for Health Research and Development (ZonMw), Vici grant 918.16.616. Dr Delewi received educational fees from Boston Scientific and Edwards Lifesciences. The other authors report no conflicts.

Funding Information:
We acknowledge support from The Netherlands CardioVascular Research Initiative: The Dutch Heart Foundation (CVON 2018-28 and 2012-06 Heart Brain Connection), Dutch Federation of University Medical Centres, The Netherlands Organisation for Health Research and Development, and The Royal Netherlands Academy of Sciences.

Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1161/STROKEAHA.123.040499

Cite this

@article{30e01fefc251413b86a1270de99ef590,

title = "Cognitive Impairment in Patients with Cardiac Disease: Implications for Clinical Practice",

abstract = "Cognitive impairment is common in patients with cardiovascular disease. One in 3 patients presenting at cardiology clinics have some degree of cognitive impairment, depending on the cardiac condition, comorbidities, and age. In up to half of these cases cognitive impairment may go unrecognized; however, it may affect self-management and treatment adherence. The high prevalence of cognitive impairment in patients with cardiac disease is likely due to shared risk factors, as well as direct consequences of cardiac dysfunction on the brain. Moreover, cardiac interventions may have beneficial as well as adverse effects on cognitive functioning. In this review, we describe prevalence and risk factors for cognitive impairment in patients with several common cardiac conditions: heart failure, coronary artery disease, and aortic valve stenosis. We discuss the potential effects of guideline-based treatments on cognition and identify open questions and unmet needs. Given the high prevalence of unrecognized cognitive impairment in cardiac patients, we recommend a stepwise approach to improve detection and management of cognitive impairment.",

author = "{Van Nieuwkerk}, {Astrid C.} and Ronak Delewi and Wolters, {Frank J.} and Majon Muller and Mat Daemen and Biessels, {Geert Jan}",

note = "Funding Information: Dr Wolters was consultant for the PGGM pension fund (fees paid to institution) and received research grants from the Brain & Behavior Research Foundation, The Netherlands Organisation for Health Research and Development (ZonMw) and The Alzheimer{\textquoteright}s Association, outside of the submitted work. Dr Biessels also receives research funding from The Netherlands Organisation for Health Research and Development (ZonMw), Vici grant 918.16.616. Dr Delewi received educational fees from Boston Scientific and Edwards Lifesciences. The other authors report no conflicts. Funding Information: We acknowledge support from The Netherlands CardioVascular Research Initiative: The Dutch Heart Foundation (CVON 2018-28 and 2012-06 Heart Brain Connection), Dutch Federation of University Medical Centres, The Netherlands Organisation for Health Research and Development, and The Royal Netherlands Academy of Sciences. Publisher Copyright: {\textcopyright} 2023 Lippincott Williams and Wilkins. All rights reserved.",

year = "2023",

month = aug,

doi = "10.1161/STROKEAHA.123.040499",

language = "English",

volume = "54",

pages = "2181--2191",

journal = "Stroke",

issn = "0039-2499",

publisher = "Wolters Kluwer Health",

number = "8",

}

TY - JOUR

T1 - Cognitive Impairment in Patients with Cardiac Disease

T2 - Implications for Clinical Practice

AU - Van Nieuwkerk, Astrid C.

AU - Delewi, Ronak

AU - Wolters, Frank J.

AU - Muller, Majon

AU - Daemen, Mat

AU - Biessels, Geert Jan

N1 - Funding Information: Dr Wolters was consultant for the PGGM pension fund (fees paid to institution) and received research grants from the Brain & Behavior Research Foundation, The Netherlands Organisation for Health Research and Development (ZonMw) and The Alzheimer’s Association, outside of the submitted work. Dr Biessels also receives research funding from The Netherlands Organisation for Health Research and Development (ZonMw), Vici grant 918.16.616. Dr Delewi received educational fees from Boston Scientific and Edwards Lifesciences. The other authors report no conflicts. Funding Information: We acknowledge support from The Netherlands CardioVascular Research Initiative: The Dutch Heart Foundation (CVON 2018-28 and 2012-06 Heart Brain Connection), Dutch Federation of University Medical Centres, The Netherlands Organisation for Health Research and Development, and The Royal Netherlands Academy of Sciences. Publisher Copyright: © 2023 Lippincott Williams and Wilkins. All rights reserved.

PY - 2023/8

Y1 - 2023/8

N2 - Cognitive impairment is common in patients with cardiovascular disease. One in 3 patients presenting at cardiology clinics have some degree of cognitive impairment, depending on the cardiac condition, comorbidities, and age. In up to half of these cases cognitive impairment may go unrecognized; however, it may affect self-management and treatment adherence. The high prevalence of cognitive impairment in patients with cardiac disease is likely due to shared risk factors, as well as direct consequences of cardiac dysfunction on the brain. Moreover, cardiac interventions may have beneficial as well as adverse effects on cognitive functioning. In this review, we describe prevalence and risk factors for cognitive impairment in patients with several common cardiac conditions: heart failure, coronary artery disease, and aortic valve stenosis. We discuss the potential effects of guideline-based treatments on cognition and identify open questions and unmet needs. Given the high prevalence of unrecognized cognitive impairment in cardiac patients, we recommend a stepwise approach to improve detection and management of cognitive impairment.

AB - Cognitive impairment is common in patients with cardiovascular disease. One in 3 patients presenting at cardiology clinics have some degree of cognitive impairment, depending on the cardiac condition, comorbidities, and age. In up to half of these cases cognitive impairment may go unrecognized; however, it may affect self-management and treatment adherence. The high prevalence of cognitive impairment in patients with cardiac disease is likely due to shared risk factors, as well as direct consequences of cardiac dysfunction on the brain. Moreover, cardiac interventions may have beneficial as well as adverse effects on cognitive functioning. In this review, we describe prevalence and risk factors for cognitive impairment in patients with several common cardiac conditions: heart failure, coronary artery disease, and aortic valve stenosis. We discuss the potential effects of guideline-based treatments on cognition and identify open questions and unmet needs. Given the high prevalence of unrecognized cognitive impairment in cardiac patients, we recommend a stepwise approach to improve detection and management of cognitive impairment.

UR - http://www.scopus.com/inward/record.url?scp=85165751799&partnerID=8YFLogxK

U2 - 10.1161/STROKEAHA.123.040499

DO - 10.1161/STROKEAHA.123.040499

M3 - Review article

C2 - 37272393

AN - SCOPUS:85165751799

SN - 0039-2499

VL - 54

SP - 2181

EP - 2191

JO - Stroke

JF - Stroke

IS - 8

ER -

Cognitive Impairment in Patients with Cardiac Disease: Implications for Clinical Practice

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this